Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

INcrease Of VAgal TonE in CHF (INOVATE-HF)

This study has been terminated.
(Futility of Primary Efficacy Endpoint)
Information provided by (Responsible Party):
BioControl Medical Identifier:
First received: February 18, 2011
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):